Sort
82,697 grants matching “vaccine development”
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$888,792Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2018 · AI
Influence of SIV replication on TB progression and immunity
$888,791Zandrea Ambrose · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AI
Virus Clearance from the Central Nervous System
$888,709Douglas Craig Hooper · Thomas Jefferson University · R01 · FY2013 · AI
Function of granulysin
$888,707Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Clinical Trials of Haploidentical Hematopoietic Stem Cell Transplantation and Vac
$888,668Nelson J. Chao · Duke University · P01 · FY2013 · CA
Targeting bacterial cell wall biogenesis for the development of novel antimicrob
$888,658Thomas G Bernhardt · Harvard Medical School · U19 · FY2015 · AI
Machine Learning for Detecting Malaria and Other Infectious Diseases
$888,509Stefan Jaeger · National Library Of Medicine · ZIA · FY2019 · LM
The functional significance of CTL escape
$888,436David I Watkins · George Washington University · R01 · FY2022 · AI
Targeting bacterial cell wall biogenesis for the development of novel antimicrob
$888,429Thomas G Bernhardt · Harvard Medical School · U19 · FY2017 · AI
Large Scale T Cell Epitope Discovery: Global identification of epitopes derived from Zika (ZIKV) and Chikungunya (CHIKV) viruses following natural infection and vaccination
$888,279Alessandro Sette · La Jolla Institute For Immunology · N01 · FY2019 · AI
Cooperative Center for the study of HCV antibody responses and vaccine antigens
$888,265Mansun Law · Scripps Research Institute, The · U19 · FY2020 · AI
Evaluation fo Live Attenuated B. Melitensis Vaccines in Nonhuman Primates
$888,236Thomas A Ficht · University Of Texas Med Br Galveston · U54 · FY2011 · AI
Human T cell responses permissive for progression to active TB disease
$888,177Joel D. Ernst · Emory University · U19 · FY2020 · AI
PROJECT 1: Design of native-like SOSIP trimers
$888,056John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2020 · AI
International Studies Of Acquired Immune Deficiency Syndrome (AIDS)
$887,990Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Durable HIV Vaccine Targeting Mucosal Epithelium
$887,962Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2024 · AI
Systems Biology Approaches to Molecular Diagnostics and Antiviral Drug Targeting
$887,917W. Ian Lipkin · Columbia University Health Sciences · U19 · FY2016 · AI
Identification of human tumor-associated antigens
$887,872Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Clinical Support
$887,848James J Vredenburgh · Duke University · P01 · FY2014 · CA
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$887,620Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
A Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA
$887,615Mark Yondola · Calder Biosciences, Inc. · R44 · FY2020 · AG
Glycan dependent epitopes of HIV broadly neutralizing antibodies
$887,498James C. Paulson · Scripps Research Institute, The · R56 · FY2020 · AI
How antigen exposure shapes the subsequent NK cell response to HIV
$887,484Silke Paust · Scripps Research Institute, The · R01 · FY2021 · AI
Physical Resources Core
$887,468Justin Joseph Pollara · Duke University · P01 · FY2021 · AI
Role of local antibodies in control of chronic genital herpes
$887,376Anton M Sholukh · Fred Hutchinson Cancer Center · R01 · FY2024 · AI